Lidia Gil
Impact in
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Papers in
- Hematology 58
- Hematopoietic Stem Cell Transplantation 21
- Acute Myeloid Leukemia Research 16
- Multiple Myeloma Research and Treatments 13
- Chronic Myeloid Leukemia Treatments 10
- Genetics 23
- Chronic Lymphocytic Leukemia Research 14
- Co-authors
- Mieczysław KomarnickiJan StyczyńskiJoanna Rupa‐MatysekPer LjungmanHermann EinseleMaciej KaźmierczakDominik DytfeldElżbieta Nowakowska
- Journals
- Bone Marrow Transplantation (7 papers)Annals of Hematology (6 papers)Medical Oncology (5 papers)Journal of Clinical Medicine (4 papers)Disease Markers (3 papers)
- Partner nations
- PolandSpainUnited States
In The Last Decade
Lidia Gil
115 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 100
- Hematology 414
- Internal Medicine 135
- Genetics 269
- Oncology 413
- Pathology and Forensic Medicine 192
Countries citing papers authored by Lidia Gil
This map shows the geographic impact of Lidia Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lidia Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lidia Gil more than expected).
Fields of papers citing papers by Lidia Gil
This network shows the impact of papers produced by Lidia Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lidia Gil. The network helps show where Lidia Gil may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lidia Gil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 6 | |
| 9 | 2021 | 9 | |
| 10 | 2021 | 5 | |
| 11 | 2021 | 1 | |
| 12 | 2020 | 10 | |
| 13 | 2020 | 6 | |
| 14 | 2019 | 2 | |
| 15 | 2019 | 2 | |
| 16 | 2017 | 4 | |
| 17 | Allogeniczne przeszczepienie krwiotwórczych komórek macierzystych w leczeniu chorych z ostrą białaczką szpikową | 2011 | 1 |
| 18 | Diagnostic and treatment strategy of invasive aspergillosis based on galactomannan screenning – prospective analysis of 268 patients after hematopoietic stem cell transplantation | 2009 | 1 |
| 19 | Activity of bortezomib in adult de novo and relapsed acute myeloid leukemia. | 2008 | 20 |
| 20 | Rituximab in haematology and oncology in 10 years of experience | 2008 | 1 |
About Lidia Gil
Lidia Gil is a scholar working on Hematology, Genetics, Internal Medicine, Oncology and Pathology and Forensic Medicine, having authored 136 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (21 papers), Acute Myeloid Leukemia Research (16 papers), Lymphoma Diagnosis and Treatment (16 papers), Chronic Lymphocytic Leukemia Research (14 papers), Multiple Myeloma Research and Treatments (13 papers), Viral-associated cancers and disorders (12 papers), Neutropenia and Cancer Infections (10 papers) and Chronic Myeloid Leukemia Treatments (10 papers). The work is most often cited by research in Hematology (414 citations), Internal Medicine (135 citations), Genetics (269 citations), Oncology (413 citations) and Pathology and Forensic Medicine (192 citations). Lidia Gil has collaborated with scholars based in Poland, Spain and United States. Frequent co-authors include Mieczysław Komarnicki, Jan Styczyński, Joanna Rupa‐Matysek, Per Ljungman, Hermann Einsele, Maciej Kaźmierczak, Dominik Dytfeld, Elżbieta Nowakowska, Katarzyna Brzeźniakiewicz‐Janus and Anna Olewicz‐Gawlik. Their work appears in journals such as Bone Marrow Transplantation, Annals of Hematology, Medical Oncology, Journal of Clinical Medicine and Disease Markers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.